Technical corrections clear Senate
This article was originally published in The Gray Sheet
Executive Summary
"Medical Device Technical Corrections Act" (S 1881) passes Senate floor vote Nov. 25 by unanimous consent. Sponsored by Sen. Lamar Alexander (R-Tenn.), the bill represents a bipartisan consensus on third-party inspections (1"The Gray Sheet" Nov. 24, 2003, p. 17). The legislation includes an 18-month moratorium on implementation of Sec. 301 of MDUFMA requiring manufacturers to put their name on devices, giving more time for FDA and Congress to weigh potential changes (2"The Gray Sheet" Oct. 27, 2003, In Brief)...
You may also be interested in...
MDUFMA Adjustments Gain Dems’ Support As Congress Heads Toward Recess
Sens. Edward Kennedy (D-Mass.) and Judd Gregg (R-N.H.) have reached consensus on the "Medical Device Technical Corrections Act" (S 1881), according to staffers
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.